256 related articles for article (PubMed ID: 27093871)
1. Clinically relevant behavioral endpoints in a recurrent nitroglycerin migraine model in rats.
Sufka KJ; Staszko SM; Johnson AP; Davis ME; Davis RE; Smitherman TA
J Headache Pain; 2016; 17():40. PubMed ID: 27093871
[TBL] [Abstract][Full Text] [Related]
2. The effects of repeated nitroglycerin administrations in rats; modeling migraine-related endpoints and chronification.
Harris HM; Carpenter JM; Black JR; Smitherman TA; Sufka KJ
J Neurosci Methods; 2017 Jun; 284():63-70. PubMed ID: 28442295
[TBL] [Abstract][Full Text] [Related]
3. Depression of home cage wheel running: a reliable and clinically relevant method to assess migraine pain in rats.
Kandasamy R; Lee AT; Morgan MM
J Headache Pain; 2017 Dec; 18(1):5. PubMed ID: 28091820
[TBL] [Abstract][Full Text] [Related]
4. Utility of different outcome measures for the nitroglycerin model of migraine in mice.
Farkas S; Bölcskei K; Markovics A; Varga A; Kis-Varga Á; Kormos V; Gaszner B; Horváth C; Tuka B; Tajti J; Helyes Z
J Pharmacol Toxicol Methods; 2016; 77():33-44. PubMed ID: 26456070
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats.
Bulboacă AE; Bolboacă SD; Stănescu IC; Sfrângeu CA; Porfire A; Tefas L; Bulboacă AC
Int J Nanomedicine; 2018; 13():3093-3103. PubMed ID: 29872296
[TBL] [Abstract][Full Text] [Related]
6. Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues.
Knapp L; Szita B; Kocsis K; Vécsei L; Toldi J
Drug Des Devel Ther; 2017; 11():27-34. PubMed ID: 28053504
[TBL] [Abstract][Full Text] [Related]
7. Duality in response of intracranial vessels to nitroglycerin revealed in rats by imaging photoplethysmography.
Sokolov AY; Volynsky MA; Potapenko AV; Iurkova PM; Zaytsev VV; Nippolainen E; Kamshilin AA
Sci Rep; 2023 Jul; 13(1):11928. PubMed ID: 37488233
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin attenuates hyperalgesia and light aversion-induced by nitroglycerin in male rats.
Farajdokht F; Babri S; Karimi P; Mohaddes G
Neurosci Lett; 2016 Sep; 630():30-37. PubMed ID: 27436480
[TBL] [Abstract][Full Text] [Related]
9. Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats.
Mahmoudi J; Mohaddes G; Erfani M; Sadigh-Eteghad S; Karimi P; Rajabi M; Reyhani-Rad S; Farajdokht F
Brain Res Bull; 2018 Jun; 140():197-204. PubMed ID: 29752991
[TBL] [Abstract][Full Text] [Related]
10. The pharmacodynamics of sumatriptan in nitroglycerin-induced headache.
Fullerton T; Komorowski-Swiatek D; Forrest A; Gengo FM
J Clin Pharmacol; 1999 Jan; 39(1):17-29. PubMed ID: 9987697
[TBL] [Abstract][Full Text] [Related]
11. The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.
Tipton AF; Tarash I; McGuire B; Charles A; Pradhan AA
Cephalalgia; 2016 Oct; 36(11):1048-1056. PubMed ID: 26682574
[TBL] [Abstract][Full Text] [Related]
12. Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide.
Farajdokht F; Babri S; Karimi P; Alipour MR; Bughchechi R; Mohaddes G
Eur J Neurosci; 2017 Mar; 45(6):763-772. PubMed ID: 27886414
[TBL] [Abstract][Full Text] [Related]
13. Infusion of low dose glyceryl trinitrate has no consistent effect on burrowing behavior, running wheel activity and light sensitivity in female rats.
Christensen SL; Petersen S; Sørensen DB; Olesen J; Jansen-Olesen I
J Pharmacol Toxicol Methods; 2016; 80():43-50. PubMed ID: 27066766
[TBL] [Abstract][Full Text] [Related]
14. Nitroglycerin facilitates calcitonin gene-related peptide-induced behavior.
Yao D; Sessle BJ
Neuroreport; 2008 Aug; 19(13):1307-11. PubMed ID: 18695513
[TBL] [Abstract][Full Text] [Related]
15. Effect of Paeonia lactiflora, a traditional Chinese herb, on migraines based on clinical application and animal behavior analyses.
Liao CC; Li JM; Chen CH; Lin CL; Hsieh CL
Biomed Pharmacother; 2019 Oct; 118():109276. PubMed ID: 31377466
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel model of chronic migraine.
Pradhan AA; Smith ML; McGuire B; Tarash I; Evans CJ; Charles A
Pain; 2014 Feb; 155(2):269-274. PubMed ID: 24121068
[TBL] [Abstract][Full Text] [Related]
17. Towards a pragmatic human migraine model for drug testing: 2. Isosorbide-5-mononitrate in healthy individuals.
Hansen EK; Olesen J
Cephalalgia; 2017 Jan; 37(1):11-19. PubMed ID: 26924839
[TBL] [Abstract][Full Text] [Related]
18. AMPA receptor GluA1 Ser831 phosphorylation is critical for nitroglycerin-induced migraine-like pain.
Tang Y; Liu S; Shu H; Xing Y; Tao F
Neuropharmacology; 2018 May; 133():462-469. PubMed ID: 29486167
[TBL] [Abstract][Full Text] [Related]
19. Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice.
Bates EA; Nikai T; Brennan KC; Fu YH; Charles AC; Basbaum AI; Ptácek LJ; Ahn AH
Cephalalgia; 2010 Feb; 30(2):170-8. PubMed ID: 19489890
[TBL] [Abstract][Full Text] [Related]
20. Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
Ben Aissa M; Tipton AF; Bertels Z; Gandhi R; Moye LS; Novack M; Bennett BM; Wang Y; Litosh V; Lee SH; Gaisina IN; Thatcher GR; Pradhan AA
Cephalalgia; 2018 Jul; 38(8):1471-1484. PubMed ID: 29022756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
